Avior Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-300
| Closed | -$150 | – | 1633 |
|
|
2024
Q4 | $150 | Hold |
300
| – | – | ﹤0.01% | 2391 |
|
|
2024
Q3 | $271 | Hold |
300
| – | – | ﹤0.01% | 2210 |
|
|
2024
Q2 | $299 | Sell |
300
-21
| -7% | -$21 | ﹤0.01% | 2162 |
|
|
2024
Q1 | $475 | Buy |
321
+21
| +7% | +$31 | ﹤0.01% | 2582 |
|
|
2023
Q4 | $327 | Hold |
300
| – | – | ﹤0.01% | 1451 |
|
|
2023
Q3 | $354 | Hold |
300
| – | – | ﹤0.01% | 1520 |
|
|
2023
Q2 | $423 | Hold |
300
| – | – | ﹤0.01% | 1474 |
|
|
2023
Q1 | $450 | Buy |
+300
| New | +$450 | ﹤0.01% | 1528 |
|